# A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

> **NCT06313528** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 85 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** LY3437943
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06313528
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-20
- **Primary completion:** 2025-08-26
- **Final completion:** 2025-08-26
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06313528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06313528, "A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06313528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*